| Theme | Metabolic Syndrome in Chronic Renal Failure | |
|---|---|---|
| Title | Influence of CAPD on dialysis patients with metabolic syndrome | |
| Publish Date | 2006/11 | |
| Author | Tadashi Uramatsu | Shinzato Nephro Clinic |
| Author | Masanobu Miyazaki | Furukawa Clinic |
| Author | Akira Furusu | The Second Department of Internal Medicine, Nagasaki University Hospital, School of Medicine and Dentistry |
| Author | Shigeru Kouno | The Second Department of Internal Medicine, Nagasaki University Hospital, School of Medicine and Dentistry |
| [ Summary ] | Metabolic syndrome is defined as a combination of several individual metabolic problems that lead to a high risk of atherosclerosis. The main features of metabolic syndrome include impaired glucose intolerance, hypertension, dyslipidemia, and obesity. In peritoneal dialysis, glucose is used as the most common osmotic agent in dialysis solution, wich is absorbed from dialysis solution and is associated with a variety of metabolic consequences ranging from acute hyperglycemia and hyperinsulinemia to dyslipidemia. In management of CAPD patients, it is important to consider the existence of metabolic syndrome to prevent cardiovascular events. | |